SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,395 | -99.5% | 39,105 | +332.4% | 0.00% | – |
| Q3 2022 | $306,000 | -91.8% | 9,044 | -95.0% | 0.00% | -100.0% |
| Q3 2020 | $3,744,000 | +0.2% | 179,631 | +14.2% | 0.01% | -14.3% |
| Q2 2020 | $3,736,000 | +634.0% | 157,318 | +455.9% | 0.01% | +600.0% |
| Q1 2020 | $509,000 | -58.6% | 28,300 | -45.3% | 0.00% | -66.7% |
| Q4 2019 | $1,228,000 | -2.2% | 51,781 | +44.5% | 0.00% | 0.0% |
| Q1 2019 | $1,256,000 | – | 35,836 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |